Getting Ahead of the Evolving Landscape in Radiopharmaceuticals, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar devoted to radiopharmaceuticals, the featured speakers will explore the scientific, operational and regulatory considerations for radiopharmaceuticals. With a focus on oncology, they will discuss the current regulatory landscape and how this impacts overall development programs. The speakers will explore the challenges of conducting radiopharmaceutical trials, offering insights into trial start-up, site selection and operational aspects to seamlessly execute these studies as part of clinical development plans.

Xtalks Life Science Webinars

There is now a sizeable development effort with many clinical trials ongoing in this area; that includes theranostics with a focus on combining molecular targeting with radiation to detect and modulate the tumor microenvironment and cause radiation-induced cell death.

Radiotherapies are dramatically changing the way patients are treated in a wide variety of diseases, particularly for patients with neuroendocrine tumors (NETs) and other oncologic indications like metastatic lung, breast and prostate cancer. There is now a sizeable development effort with many clinical trials ongoing in this area; that includes theranostics with a focus on combining molecular targeting with radiation to detect and modulate the tumor microenvironment and cause radiation-induced cell death. Consequently, the dynamic market for innovative radiopharmaceuticals, whether they are intended for therapeutic or diagnostic purposes, has grown globally.

Academic institutions and biotech companies are increasingly contributing to these developments both in terms of scientific discovery and commercialization efforts. They aim for regulatory approval to image and/or treat specific oncology populations. Well-informed radiopharmaceutical clinical research and development remain crucial for getting diagnostic and therapeutic innovations to patients.

Join experts from Medpace’s radiation oncology, imaging, regulatory and operational team as they explore regulatory considerations, oncology trial management, and imaging advancements in a live webinar on Wednesday, March 4, 2020 at 11am EST (4pm GMT/UK).

For more information or to register for this event, visit Getting Ahead of the Evolving Landscape in Radiopharmaceuticals.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Margot Rubin
Xtalks
+1 416.977.6555 x 352
Email >
Visit website